Shire Hits ‘Sweet Spot’ With $750 Million U.S. Acquisition

Shire Plc, the Irish maker of treatments for attention-deficit disorder, said it agreed to buy closely held Advanced BioHealing Inc. for $750 million in cash, a day before the biotechnology company was to go public.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.